Skip to Content

Mission Statement

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

Mission Statement

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

Mission Statement

Folder: Technology

What are iNKT cells?

Solid Tumour Strategies

Publications & Conference Proceedings

Folder: Products

ALA-101: CAR19-iNKT

ALA-105: CLDN18.2-iNKT

Folder: Investors

Investor Centre

ASX Announcements

News & Presentations

Financial Reports

Analyst Coverage

News & Presentations

Filter by Category

All 99
Company News 37
Media 23
Newsletter 9
Presentations & Webinars 32

Arovella Newsletter July 2022

Newsletter, All Michelle Long 26/7/22 Newsletter, All Michelle Long 26/7/22

Arovella Newsletter July 2022

Read More

investor@arovella.com
+61.3.9863.6472

Subscribe to our Newsletters

Email Address

Thank you for joining the database for Arovella Therapeutics - we will contact you with upcoming investor relation news.

Site by BDAC Media